PD-Rx Pharmaceuticals, Inc. (PDRX)

USD 3.2

(-13.51%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 21.27 Million 28.71 Million 21.6 Million 21.02 Million 20.87 Million 24.96 Million
Cost of Revenue 14.55 Million 17.65 Million 14.64 Million 14.76 Million 13.28 Million 16.43 Million
Gross Profit 6.71 Million 11.06 Million 6.95 Million 6.25 Million 7.58 Million 8.53 Million
Operating Expenses 6.9 Million 7.02 Million 6.08 Million 6.49 Million 7.65 Million 7.64 Million
Selling, General and Administrative Expenses 6.9 Million 7.05 Million 6.08 Million 6.49 Million 7.65 Million 7.64 Million
Research and Development Expenses - - - - - -
Other Expenses - - - - - -
Cost and Expenses 21.46 Million 24.67 Million 20.72 Million 21.26 Million 20.93 Million 24.07 Million
Operating Income -190.47 Thousand 4 Million 876.47 Thousand -237.65 Thousand -65.73 Thousand 890.72 Thousand
Interest Expense - - - - - -
Income Tax Expense 28.71 Thousand 1.01 Million -21.63 Thousand 183.6 Thousand -1516.00 359.63 Thousand
Earnings before Tax -126.77 Thousand 4.05 Million 1.83 Million -200.53 Thousand -14.43 Thousand 980.8 Thousand
Net Income -98.06 Thousand 3.03 Million 1.85 Million -384.14 Thousand -12.91 Thousand 621.16 Thousand
Earnings Per Share Basic -0.06 1.83 1.08 -0.22 -0.01 0.36
Earnings Per Share Diluted -0.06 1.83 1.08 -0.22 -0.01 0.36
Weighted Average Shares Outstanding 1.63 Million 1.65 Million 1.71 Million 1.71 Million 1.71 Million 1.71 Million
Weighted Average Shares Outstanding (Diluted) 1.63 Million 1.65 Million 1.71 Million 1.71 Million 1.71 Million 1.71 Million
Gross Margin 0.32 0.39 0.32 0.30 0.36 0.34
EBIT Margin -0.00 0.14 0.05 -0.00 0.01 0.04
Profit Margin -0.00 0.11 0.09 -0.02 -0.00 0.02
EBITDA -51.41 Thousand 4.13 Million 1.94 Million -39.5 Thousand 162.89 Thousand 1.15 Million
Earnings Before Tax Margin -0.01 0.14 0.04 -0.01 -0.00 0.04

Income Statement Charts